June 16, 2017 / 7:31 AM / 3 months ago

BRIEF-Zeria Pharmaceutical ends license agreement with EA Pharma

June 16 (Reuters) - Zeria Pharmaceutical Co Ltd

* Says it ends a license agreement with EA Pharma Co Ltd, regarding proton pump inhibitor E3710

* Says it returns the exclusive development rights, joint sales rights and non-exclusive manufacture rights of inhibitor E3710

Source text in Japanese:goo.gl/VvTAUN

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below